(Total Views: 517)
Posted On: 01/07/2019 8:17:41 AM
Post# of 75419
I just took a look at Celsius, which many people cite as a sort of predecessor company of RMHB. (Healthy drink, David/Harrington in management, etc.) It's currently at $3.38. It has 173M shares and it showed a record $16.6M in revenue for the 3rd Q of 2018.
There's good and bad news for us in this. They're at an annualized revenue of $64M after quite a few years in business. I fully expect us to hit that number in 2019, 2020 at the latest. That's a mighty quick climb! But then there's our stock structure. As I understand it, we have about 10x more shares issued (as distinguished from authorized) than Celsius. That would put our stock price at 34 cents if we did an apples-to-apples comparison.
Overall, I see lots of potential in this. Given what I expect to unfold over the course of the coming year, I'd expect us to hit 50 cents at a minimum. This is based on revenue for the year coming in at $50M or more and on the beginnings of a stock buy-down. I'm seeing a reduction of up to 20-25% over the course of the year ahead, although that may take a bit longer in reality.
There's good and bad news for us in this. They're at an annualized revenue of $64M after quite a few years in business. I fully expect us to hit that number in 2019, 2020 at the latest. That's a mighty quick climb! But then there's our stock structure. As I understand it, we have about 10x more shares issued (as distinguished from authorized) than Celsius. That would put our stock price at 34 cents if we did an apples-to-apples comparison.
Overall, I see lots of potential in this. Given what I expect to unfold over the course of the coming year, I'd expect us to hit 50 cents at a minimum. This is based on revenue for the year coming in at $50M or more and on the beginnings of a stock buy-down. I'm seeing a reduction of up to 20-25% over the course of the year ahead, although that may take a bit longer in reality.
(10)
(1)
